Alcon Inc (ALC) stock
ALCNYSEOphthalmic GoodsFiscal year ends December 31
$74.12+2.29 (+3.19%)
Close on Nov 13, 2026Market cap $36.13BP/E 37.4Yield –
Alcon EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Alcon's EPS for the twelve months ending Dec 31, 2010 was $7.27, up 9.2% year over year. For fiscal 2025 it was $1.98, down 3.4% from the year before. Over ten years it grew -11.4% a year on average. The highest annual figure on record is $7.27 in fiscal 2010.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.98 | -3.4% |
| FY2024 | Dec 31, 2024 | $2.05 | +4.6% |
| FY2023 | Dec 31, 2023 | $1.96 | +188.2% |
| FY2022 | Dec 31, 2022 | $0.68 | -10.5% |
| FY2021 | Dec 31, 2021 | $0.76 | – |
| FY2020 | Dec 31, 2020 | -$1.09 | – |
| FY2019 | Dec 31, 2019 | -$1.34 | – |
| FY2018 | Dec 31, 2018 | -$0.46 | -188.5% |
| FY2017 | Dec 31, 2017 | $0.52 | -92.8% |
| FY2010 | Dec 31, 2010 | $7.27 | +9.2% |
| FY2009 | Dec 31, 2009 | $6.66 | -1.9% |
| FY2008 | Dec 31, 2008 | $6.79 | +29.3% |
| FY2007 | Dec 31, 2007 | $5.25 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0.00 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $0.35 | +12.9% |
| Q2 FY2024 | Jun 30, 2024 | $0.45 | – |
| Q2 FY2023 | Jun 30, 2023 | $0.34 | – |
| Q2 FY2022 | Jun 30, 2022 | $0.30 | +900.0% |
| Q2 FY2021 | Jun 30, 2021 | $0.31 | -81.9% |
| Q2 FY2020 | Jun 30, 2020 | -$0.86 | -158.5% |
| Q2 FY2019 | Jun 30, 2019 | -$0.80 | -136.2% |
| Q2 FY2018 | Jun 30, 2018 | $0.03 | -98.4% |
| Q4 FY2010 | Dec 31, 2010 | $1.71 | +13.2% |
| Q3 FY2010 | Sep 30, 2010 | $1.47 | -14.0% |
| Q2 FY2010 | Jun 30, 2010 | $2.21 | +13.9% |
| Q1 FY2010 | Mar 31, 2010 | $1.89 | +25.2% |
| Q4 FY2009 | Dec 31, 2009 | $1.51 | -27.1% |
| Q3 FY2009 | Sep 30, 2009 | $1.71 | -9.0% |
| Q2 FY2009 | Jun 30, 2009 | $1.94 | – |
| Q1 FY2009 | Mar 31, 2009 | $1.51 | – |
| Q3 FY2008 | Sep 30, 2008 | $2.07 | – |
| Q2 FY2008 | Jun 30, 2008 | $1.88 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?